Publicacions en què col·labora amb José Luis López Guerra (18)

2021

  1. A data mining based clinical decision support system for survival in lung cancer

    Reports of Practical Oncology and Radiotherapy, Vol. 26, Núm. 6, pp. 839-848

  2. Prognostic value of the TGFβ1 rs4803455 single nucleotide polymorphism in small cell lung cancer

    Tumori, Vol. 107, Núm. 3, pp. 209-215

2020

  1. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study

    Clinical and Translational Oncology, Vol. 22, Núm. 9, pp. 1635-1644

2019

  1. Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer

    Radiotherapy and Oncology, Vol. 135, pp. 161-169

  2. Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment

    Clinical and Translational Oncology, Vol. 21, Núm. 9, pp. 1220-1230

  3. Late toxicity for prostate cancer patients treated with hypofractionated helical tomotherapy

    Reports of Practical Oncology and Radiotherapy, Vol. 24, Núm. 3, pp. 298-305

  4. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer

    Clinical and Translational Oncology, Vol. 21, Núm. 7, pp. 881-890

  5. The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation

    Radiotherapy and Oncology, Vol. 136, pp. 29-36

2018

  1. High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions

    Radiotherapy and Oncology, Vol. 127, Núm. 2, pp. 219-224

  2. Long-term outcomes after radiosurgery for glomus jugulare tumors

    Tumori, Vol. 104, Núm. 4, pp. 300-306

2017

  1. Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients

    Clinical and Translational Oncology, Vol. 19, Núm. 12, pp. 1469-1477

2016

  1. Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors

    Oncogene, Vol. 35, Núm. 21, pp. 2777-2788

2015

  1. Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma

    Clinical and Translational Oncology, Vol. 17, Núm. 11, pp. 925-931

  2. Ethnic difference in risk of toxicity in prostate cancer patients treated with dynamic arc radiation therapy

    Tumori, Vol. 101, Núm. 4, pp. 461-468

  3. High casein kinase 1 epsilon levels are correlated with better prognosis in subsets of patients with breast cancer

    Oncotarget, Vol. 6, Núm. 30, pp. 30343-30356

2013

  1. Preliminary study of automatic extraction of breast cancer staging from free text clinical reports

    Revista de Senologia y Patologia Mamaria, Vol. 26, Núm. 2, pp. 41-46

2012

  1. Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol

    Clinical and Translational Oncology, Vol. 14, Núm. 4, pp. 294-301

2011

  1. Health related quality of life and late side effects of long-term survivors of Ewing's sarcoma of bone

    Journal of B.U.ON., Vol. 16, Núm. 3, pp. 528-536